Active Ankylosing spondylitis
Drug | Drug Name | Drug Description |
---|---|---|
DB08904 | Certolizumab pegol | A tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis. |
DB06674 | Golimumab | A TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. |
DB11569 | Ixekizumab | A monoclonal antibody used to treat moderate to severe plaque psoriasis. |
DB09029 | Secukinumab | An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. |
DB08895 | Tofacitinib | A Janus kinase (JAK) inhibitor used to treat rheumatic conditions, such as rheumatoid arthritis and ankylosing spondylitis, and ulcerative colitis. |
DB15091 | Upadacitinib | An oral Janus kinase (JAK)1-selective inhibitor used in the treatment of moderate to severe rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, and severe atopic dermatitis, including in patients who did not respond well to other therapies. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08895 | Tofacitinib | 2 | Recruiting | 1 |
DB08904 | Certolizumab pegol | 3 | Completed | 1 |
DB08895 | Tofacitinib | Not Available | Recruiting | 1 |